Viral Genome Sequencing via Microfluidic Encapsulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for genomic sequencing of viruses are not well-suited to detect genomic variation among viral particles in a sample and are prone to biases, particularly in environmental samples, and are limited in their ability to recover small or RNA viruses and complex samples.

Innovation Solution

The method involves encapsulating individual genetic elements in semi-permeable microcapsules, amplifying the genetic material within these capsules, and sequencing the amplified material, which includes steps like cryopreservation, enrichment for extracellular genetic elements, and barcoding to improve the detection and quantification of viral genomes in various sample types.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If bulk extraction and sequencing of viral nucleic acids is used, then sequencing coverage is achieved, but genomic variation among individual viral particles cannot be detected

Engineering Contradiction:
Improvedetection of genomic variationVSAvoidsequencing method complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The bulk sample is segmented into individual viral particles through microfluidic encapsulation, where each viral particle is isolated in a separate droplet or microcapsule. This segmentation enables individual genomic sequencing while maintaining high-throughput capability, resolving the contradiction between detecting genomic variation and method complexity.

Inventive Principle:
Principle #1Segmentation

2Reliability

If metagenome assembly is used, then viral genomes can be recovered, but genomes from complex samples and environmental samples remain unrecoverable

Engineering Contradiction:
Improveviral genome recoveryVSAvoidapplicability to complex samples
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The method performs preliminary enrichment and isolation of individual viral particles before sequencing through microfluidic encapsulation. This preliminary action separates viral particles from complex environmental matrices, enabling reliable genome recovery from complex and environmental samples that would otherwise be unrecoverable by bulk metagenome assembly.

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If FACS-based genomics is used, then individual viral particles can be analyzed, but small viruses and RNA viruses are limited

Engineering Contradiction:
Improveindividual particle analysisVSAvoidcoverage of virus types
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The microfluidic encapsulation platform provides universal applicability across different virus types including small viruses and RNA viruses. The system uses size-independent encapsulation mechanisms and compatible lysis/amplification protocols that work across diverse viral genomes, eliminating the limitations of FACS-based methods while maintaining individual particle analysis capability.

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Productivity

If bulk sequencing is used, then sequencing throughput is maintained, but biases are introduced particularly in environmental samples

Engineering Contradiction:
Improvesequencing throughputVSAvoidsequencing accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

By segmenting the bulk sample into individual viral particle encapsulations, the method eliminates bulk extraction biases while maintaining high-throughput sequencing capability. Each individual particle is processed separately through lysis and amplification, ensuring unbiased representation of environmental viral diversity while preserving sequencing productivity through parallel processing.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the recovery of viral genomes that cannot be detected using previous methods, particularly from complex samples like sediments and environmental samples, and provides more accurate and complete genomic sequences, improving the detection of viral load and evolution monitoring.

Implementation Method 1

encapsulating aliquots of a liquid sample in semi-permeable microcapsules to generate a plurality of encapsulated aliquots

Methodology Applied
Scientific EffectSemipermeable Membrane: Semipermeable Membrane

Implementation Method 2

exposing the plurality of encapsulated aliquots to amplification conditions to amplify genomic material within the encapsulated aliquots

Methodology Applied
Scientific EffectDNA Amplification: Enzyme

Data Source

PatentUS20230383370A1Methods of sequencing individual viral genomes
Publication Date: 2023.11.30 BIGELOW LAB FOR OCEAN SCI
  • US20230383370A1 patent drawing
  • US20230383370A1 patent drawing
  • US20230383370A1 patent drawing

AI summary

Described herein are methods of sequencing individual viral genomes and methods of determining the viral load of a sample. Also disclosed herein are methods of monitoring the evolution of a viral genome.